Cambridge Trust CO Catalent, Inc. Transaction History

Cambridge Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 09, 2023	BUY	$41.39 - $81.0 $2,317 - $4,536	56 Added 35.67%	213 $10,000
Q3 2022 Nov 07, 2022	BUY	$72.36 - $113.1 $361 - $565	5 Added 3.29%	157 $11,000
Q2 2022 Aug 16, 2022	SELL	$87.2 - $114.05 $37,060 - $48,471	-425 Reduced 73.66%	152 $16,000
Q1 2022 May 12, 2022	BUY	$94.19 - $124.49 $14,316 - $18,922	152 Added 35.76%	577 $64,000
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $50,817 - $59,104	425 New	425 $54,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

Stay updated on Cambridge Trust CO with notifications on news.